Alan J. Main - Feb 28, 2025 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
EVP, Innov & Chem Sciences
Signature
/s/ Alan J. Main, Ph.D.
Stock symbol
LXRX
Transactions as of
Feb 28, 2025
Transactions value $
-$29,101
Form type
4
Date filed
3/3/2025, 04:32 PM
Previous filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +25.7K +10.04% 281K Feb 28, 2025 Direct F1
transaction LXRX Common Stock Options Exercise +32.9K +11.69% 314K Feb 28, 2025 Direct F1
transaction LXRX Common Stock Options Exercise +68.2K +21.71% 383K Feb 28, 2025 Direct F1
transaction LXRX Common Stock Tax liability -$29.1K -43.4K -11.35% $0.67 339K Feb 28, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -25.7K -100% 0 Feb 28, 2025 Common Stock 25.7K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -32.9K -50% 32.9K Feb 28, 2025 Common Stock 32.9K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -68.2K -33.33% 136K Feb 28, 2025 Common Stock 68.2K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.